Elixir Research & Development

The company’s R&D strengths are in developing intellectual property in non-infringing processes and resolving complex formulation challenges. Elixir Research is in the process of developing new drug delivery systems, new dosage formulations, and applying new technology for better processes.

The Centre meets CGLP requirements, and is focused on the areas of Pharmaceutical development for generics and new chemical entities, analytical research and novel drug delivery systems.

  • Research and Development laboratory for taking lab scale batches
  • Complete impurity profiling in all products developed.
  • Pilot Plant in the GMP facility to take Exhibit Batches
  • Development of analytical methods and specifications from raw materials to non-compendial finished products.
  • Co-Development of latest molecules in collaboration with global Pharmaceutical organizations.
  • A dedicated team of scientists and chemists continuously work on new molecules to effect the technology transfer into the region.
  • Accelerated and real-time stability studies.
This reflects the Company’s commitment towards developing innovative technologies and creating a knowledge base in new chemical entities pre-formulation and formulation development for Phase 1 to Phase IV NDA’s, high quality generic formulations and development of drug delivery systems.